AR and urothelial carcinoma: In summary, our data demonstrate significant AR expression in about 20% of urothelial carcinomas and a link between AR positivity and poorer overall survival in male patients with pT2–pT4 disease in univariate analyses, although this association does not remain significant after adjustment for established prognostic factors.